Rising Sexual Health Awareness To Drive Genital Herpes Market Growth: A Key Driver Powering Genital Herpes Market Growth In 2025

The Genital Herpes Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Genital Herpes Market Size and Its Estimated Growth Rate?
The genital herpes market has experienced strong growth in recent years. It will grow from $2.19 billion in 2024 to $2.34 billion in 2025, at a compound annual growth rate (CAGR) of 7.1%. The historic growth is attributed to greater awareness and diagnosis, advancements in treatment options, improved access to healTH*Care, public health campaigns, and socio-demographic factors.

The genital herpes market is projected to see strong growth, reaching $3.05 billion by 2029 at a CAGR of 6.8%. The growth is attributed to increased awareness, advancements in treatments and vaccines, rising incidence rates, digital health technologies, and expanding healTH*Care access. Major trends include telemedicine adoption, advancements in antiviral treatments, vaccine development, expanded healTH*Care access, awareness campaigns, and AI and data analytics integration.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17161

How Are Emerging Segments Shaping the Genital Herpes Market Landscape?
The genital herpes market covered in this report is segmented -

1) By Type: Diagnosis, Treatment
2) By Route Of Administration: Oral, Injectable, Topical
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channel

Subsegments:
1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests, Viral Culture Tests, Blood Antibody Tests (Serology), Antigen Detection Tests, Point-Of-Care Rapid Tests
2) By Treatment: Antiviral Medications, Acyclovir, Valacyclovir, Famciclovir, Topical Treatments, Acyclovir Cream, Docosanol Cream, Preventive Therapies, Suppressive Therapy, Prophylactic Vaccines (Under Development), Pain Management Medications, Analgesics, Topical Anesthetics

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17161&type=smp

Which Growth Factors Are Influencing Genital Herpes Market Expansion?
The increasing emphasis on sexual health is projected to propel the genital herpes market. With rising awareness of the link between sexual well-being and overall health, more individuals are seeking diagnosis, treatment, and counseling services for conditions like genital herpes. For instance, in January 2024, the UK's Local Government Association reported nearly 4.5 million sexual health consultations in 2022-an increase of 33%-alongside a 13% rise in diagnostic tests. Therefore, the enhanced focus on sexual health is accelerating growth in the genital herpes market.

Who Are the Dominant Players Across Different Genital Herpes Market Segments?
Major companies operating in the genital herpes market are Pfizer Inc, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, BioNTech SE, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi AG, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Bausch + Lomb Corporation, Dr. Reddy's Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Romark Laboratories, Eurocine Vaccines AB, Vical Incorporated

What Are the Major Trends Shaping the Genital Herpes Market?
Prominent businesses in the genital herpes market are utilizing strategic partnerships to bolster their technological capacities and broaden their market access. Such partnerships typically involve a cooperative relationship between two or more firms that pool their resources, skills, and efforts to pursue shared goals or objectives. For example, in June 2022, Eurocine Vaccines AB, a biotech firm based in Sweden and focusing on herpes illness treatment therapies and products, unveiled a research and collaboration pact with Redbiotec AG, a Swiss biotech company. This pact grants exclusive universal rights for the development, manufacture, and sale of vaccine candidates aimed at Herpes Simplex Virus Type 2 (HSV-2). The agreement includes both mRNA and protein-based technologies, as well as related documentation and patents in the HSV-2 arena. Eurocine Vaccines will manage and fund all tasks associated with development, manufacture, and commercialization until an out-licensing agreement with another party is concluded.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Which Geographic Regions Are Expected to Dominate the Genital Herpes Market in the Coming Years?
North America was the largest region in the genital herpes market in 2023. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Genital Herpes Market?
2. What is the CAGR expected in the Genital Herpes Market?
3. What Are the Key Innovations Transforming the Genital Herpes Industry?
4. Which Region Is Leading the Genital Herpes Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.